S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Avoro Capital Advisors/Q1 2024

Avoro Capital Advisors

Period: Q1 2024 Β· Filed: 2024-05-15
View on SEC EDGAR β†—
AUM
$8.57B
Total portfolio value
Positions
46
Reported securities
Top Holding
UTHR
7.7% $656.7M
QoQ Changes
+8 / -7
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-05-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
UTHRUNITED THERAPEUTICS CORP$656.7M7.66%$228.26$555.91+143.5%
7.7%
APLSAPELLIS PHARMACEUTICALS INC$653.1M7.62%$59.71β€”
7.6%
ASNDASCENDIS PHARMA$599.6M6.99%$151.98$274.50+80.6%
7.0%
SRPTSAREPTA THERAPEUTICS INC$562.4M6.56%$128.40$19.28-85.0%
6.6%
MDGLMADRIGAL PHARMACEUTICALS INC$519.2M6.06%$255.74$528.10+106.5%
6.1%
ARGXARGENX SE$487.6M5.69%$397.33$939.68+136.5%
5.7%
KRYSKRYSTAL BIOTECH INC$454.7M5.30%$176.07$375.07+113.0%
5.3%
XBISPDR SERIES TRUST - S&P BIOTECH$408.0M4.76%$93.28$160.46+72.0%
4.8%
BMRNBIOMARIN PHARMACEUTICAL INC$381.2M4.45%$87.10$58.99-32.3%
4.5%
FOLDAMICUS THERAPEUTICS INC$322.8M3.76%β€”β€”
3.8%
CERECEREVEL THERAPEUTICS HLDNG$319.4M3.73%β€”β€”
3.7%
VKTXVIKING THERAPEUTICS INC$294.4M3.43%$79.50$37.44-52.9%
3.4%
ARWRARROWHEAD PHARMACEUTICALS INC$244.7M2.85%$28.24$83.99+197.4%
2.9%
XENEXENON PHARMACEUTICALS INC$243.9M2.85%$42.14$60.96+44.7%
2.9%
ALPNALPINE IMMUNE SCIENCES INC$228.9M2.67%β€”β€”
2.7%
VERAVERA THERAPEUTICS INC$227.0M2.65%$42.35$41.20-2.7%
2.6%
IOVAIOVANCE BIOTHERAPEUTICS INC$173.4M2.02%$14.19$4.31-69.6%
2.0%
ITCIINTRA-CELLULAR THERAPIES INC$171.3M2.00%β€”β€”
2.0%
KYMRKYMERA THERAPEUTICS INC$156.3M1.82%$39.42$113.51+187.9%
1.8%
RNAMAVIDITY BIOSCIENCES INC$148.7M1.73%β€”β€”
1.7%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$129.6M1.51%$48.60$18.95-61.0%
1.5%
SNDXSYNDAX PHARMACEUTICALS INC$100.5M1.17%$23.78$21.82-8.2%
1.2%
MGNXMACROGENICS INC$90.5M1.06%$14.02$4.71-66.4%
1.1%
KURAKURA ONCOLOGY INC$82.1M0.96%$21.82$11.10-49.1%
1.0%
AUTLAUTOLUS THERAPEUTICS PLC$78.8M0.92%$5.68$1.58-72.2%
0.9%
SYRESPYRE THERAPEUTICS INC$69.8M0.81%$37.00$86.63+134.1%
0.8%
SLNOSOLENO THERAPEUTICS INC$69.5M0.81%$41.49β€”
0.8%
BCRXBIOCRYST PHARMACEUTICALS INC$66.3M0.77%$5.05$9.84+94.8%
0.8%
OCULOCULAR THERAPEUTIX INC$65.1M0.76%$8.69$9.64+10.9%
0.8%
TSHATAYSHA GENE THERAPIES INC$53.5M0.62%$2.84$6.53+129.9%
0.6%

Quarter-on-Quarter Activity

Q1 2024 vs. Q4 2023

New Positions (8)

TickerIssuerNotionalSince Filing
VKTXVIKING THERAPEUTICS INC$294.4M-52.9%
ALPNALPINE IMMUNE SCIENCES INC$228.9M
VERAVERA THERAPEUTICS INC$227.0M-2.7%
MGNXMACROGENICS INC$90.5M-66.4%
AUTLAUTOLUS THERAPEUTICS PLC$78.8M-72.2%
OCULOCULAR THERAPEUTIX INC$65.1M+10.9%
PCVXVAXCYTE INC$39.3M
CGONCG ONCOLOGY INC$30.7M

Exited Positions (7)

TickerIssuerNotional
MRTXMIRATI THERAPEUTICS INC$287.1M
CBAYCYMABAY THERAPEUTICS INC$262.4M
GPCRSTRUCTURE THERAPEUTICS INC$95.1M
KRTXKARUNA THERAPEUTICS INC$39.6M
IMGNIMMUNOGEN INC$25.9M
FENCFENNEC PHARMACEUTICALS INC$13.5M
NUVLNUVALENT INC$13.2M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
ARWRARROWHEAD PHARMACEUTICALS INC$210.1M+657.1%+197.4%
TSHATAYSHA GENE THERAPIES INC$45.8M+328.2%+129.9%
TRMLTOURMALINE BIO INC$28.1M+155.9%
RAREULTRAGENYX PHARMACEUTICAL INC$22.0M+137.1%
RNAMAVIDITY BIOSCIENCES INC$125.9M+132.1%
SLNOSOLENO THERAPEUTICS INC$38.0M+107.0%
IOVAIOVANCE BIOTHERAPEUTICS INC$118.9M+74.6%-69.6%
MRNSMARINUS PHARMACEUTICALS INC$3.2M+31.4%

Trimmed (3)

TickerIssuerNotionalShares Ξ”Since Filing
ALNYALNYLAM PHARMACEUTICALS INC$-167.8M-73.0%
XBISPDR SERIES TRUST - S&P BIOTECH$11.2M-3.2%+72.0%
KRYSKRYSTAL BIOTECH INC$136.4M-0.4%+113.0%
← Back to Hedge Funds